ASSOCIATION OF VA SURGEONS

Frequency of Surgery Cancellations Associated With Myocardial Infarction or Death 6 Months After Coronary Stent Placement
Observational studies report a decreased risk of postoperative adverse cardiac events among patients following percutaneous coronary intervention (PCI) when surgery is more than 6 months after coronary stent placement [1] [2] [3] [4] ; however, the frequency and timing of surgery cancellations due to preoperative adverse cardiac events or death in the interval between the scheduling of the procedure and the procedure itself is unknown. Changes in medical condition may account for 28% of surgery cancellations. 5 In addition, prior research on adverse postoperative events may be biased by the unavoidable selection criterion that a patient must first experience surgery in order to be studied. 6 With little information on the frequency and factors associated with surgery cancellations following PCI, it is difficult to quantify the impact of this bias. We hypothesize that surgery cancellations are more frequent in the first 6 months following the placement of a drug-eluting stent (DES) and that a higher proportion of early cancellations are associated with acute myocardial infarction (MI) or death. The VA Medical SAS files were used to define demographics and other comorbidities present at the time of stent placement. The characteristics of the scheduled surgical procedures were compared using χ 2 test statistics. Analyses were then limited to only cancelled surgical procedures, and the characteristics of cancellations related to MI or death were examined using the χ 2 test.
Methods
Results | Of the 33 046 scheduled noncardiac surgical procedures within 2 years of PCI, 4387 (13.3%) were cancelled, with 46.7% of these cancelled surgical procedures proceeding to subsequent surgery (47.2% to DES placement and 46.2% to bare metal stent [BMS] placement; P = .53). Cancellations were more frequent among patients with a BMS (14.2%) than among patients with a DES (12.4%) (P < .001) and were highest among patients with a history of chronic kidney disease (16.6%; P < .001) or a recent episode of congestive heart failure (16.0%; P < .001). They were also more common for planned digestive (23.3%) or vascular (17.1%) procedures (P < .001; Table) . Cancellation rates were highest in the first 6 months following stent placement (15.1% for <6 months vs 12.6% for >6 months; P < .001) and remained significantly elevated among patients with a BMS beyond 6 months (13.5% of patients with a BMS vs 11.8% of patients with a DES; P < .001).
Death or an MI diagnosis accompanied 6.0% of cancellations (4.2% of completed surgical procedures; P < .001) and was more frequent among cancellations within 6 months following PCI (8.5%) compared with those beyond 6 months (4.9%) (P < .001; Figure) . Cancellations related to MI or death were more frequent among patients whose stent was placed for an MI (9.4%; P < .001) and among planned respiratory (10.4%) or vascular procedures (8.7%) (P < .001). The proportion of cancellations related to death or MI did not vary by stent type (5.9% with DES vs 5.9% with BMS; P > .99). 
